Kamada (KMDA) Current Assets (2012 - 2026)
Kamada (KMDA) posted quarterly Current Assets of $199.2 million for Q1 2026, up 5.69% year-on-year from $188.5 million in Q1 2025, and up 3.19% on a QoQ basis from $193.1 million in Q4 2025.
Kamada (KMDA) Current Assets (2012 - 2026) Analysis & Trends
Kamada (KMDA) has reported Current Assets for 13 consecutive years, with $199.2 million the latest figure, recorded in Q1 2026.
- Quarterly Current Assets rose 5.69% year-over-year to $199.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $199.2 million (up 5.69% YoY) and the FY2025 annual result came in at $193.1 million, up 4.73% from the prior year.
- Current Assets improved to $199.2 million in Q1 2026 per KMDA's latest filing, from $193.1 million in the prior quarter.
- Over the last five years, Current Assets for KMDA reached as high as $199.2 million in Q1 2026 and fell as low as $131403.0 in Q1 2023.
- A 5-year average of $144.5 million and a median of $164.4 million in 2024 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2022 — Current Assets tumbled 99.92% — and 2024, when it soared 119994.67%.
- Year by year, Current Assets stood at $139.0 million in 2022, then gained by 22.27% to $170.0 million in 2023, then climbed by 8.46% to $184.3 million in 2024, then gained by 4.73% to $193.1 million in 2025, then grew by 3.19% to $199.2 million in 2026.
- According to Business Quant data, Current Assets over the past three periods registered $199.2 million, $193.1 million, and $192.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 6.05 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 13.71 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 6.47 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 19.71 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 2.87 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 53.60 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 10.92 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 2.44 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.58 Bn |
| 10 | Kamada | 401.22 Mn | 328.07 Mn | 19.12 Mn | 199.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 199.24 Mn |
| Dec 31, 2025 | 193.08 Mn |
| Sep 30, 2025 | 192.73 Mn |
| Jun 30, 2025 | 183.27 Mn |
| Mar 31, 2025 | 188.50 Mn |
| Dec 31, 2024 | 184.35 Mn |
| Sep 30, 2024 | 164.41 Mn |
| Jun 30, 2024 | 166.43 Mn |
| Mar 31, 2024 | 157.81 Mn |
| Dec 31, 2023 | 169.96 Mn |
| Sep 30, 2023 | 153.15 Mn |
| Jun 30, 2023 | 129.68 Mn |
| Mar 31, 2023 | 131,403.00 |
| Dec 31, 2022 | 139.01 Mn |
| Sep 30, 2022 | 135,162.00 |
| Jun 30, 2022 | 118.60 Mn |
| Mar 31, 2022 | 116.16 Mn |
| Dec 31, 2021 | 130.04 Mn |
| Sep 30, 2021 | 178.94 Mn |
| Jun 30, 2021 | 179.35 Mn |